Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefania Pittaluga

Showing results (81-90 of 358) with videos related to

Pageof 36
Sort By:
Blood|October 14, 2004
Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumorsLiliana Guedez, Antonio Martinez, Shumei Zhao, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 10, 2004
Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarrayHongbin Zha, Mark Raffeld, Lu Charboneau, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 20, 2009
Follicular lymphomas with plasmacytic differentiation include two subtypesJoel F Gradowski, Elaine S Jaffe, Roger A Warnke, et al.
Blood|March 10, 2011
Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphomaStefan D Dojcinov, Girish Venkataraman, Stefania Pittaluga, et al.
Blood|March 25, 2014
Ibrutinib inhibits BCR and NF-κB signaling and reduces tumor proliferation in tissue-resident cells of patients with CLLSarah E M Herman, Rashida Z Mustafa, Jennifer A Gyamfi, et al.
Blood|April 29, 2006
Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphomaMartina Rudelius, Stefania Pittaluga, Satoshi Nishizuka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 2015
A patient with Fever and rashMackenzie K Morgan, Timothy J Whitman, Jeffrey I Cohen, et al.
Cell Cycle (Georgetown, Tex.)|August 23, 2013
Loss of the proteins Bak and Bax prevents apoptosis mediated by histone deacetylase inhibitorsCaterina Ierano, Arup R Chakraborty, Alina Nicolae, et al.
Pediatrics|October 20, 2010
Highly variable clinical phenotypes of hypomorphic RAG1 mutationsElizabeth Mannino Avila, Gulbu Uzel, Amy Hsu, et al.
The American Journal of Surgical Pathology|February 28, 2012
Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphomaFranziska C Eberle, Joo Y Song, Liqiang Xi, et al.
Pageof 36

Showing results (81-90 of 358) with videos related to

Sort By:
Pageof 36
Blood|October 14, 2004
Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumorsLiliana Guedez, Antonio Martinez, Shumei Zhao, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 10, 2004
Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarrayHongbin Zha, Mark Raffeld, Lu Charboneau, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 20, 2009
Follicular lymphomas with plasmacytic differentiation include two subtypesJoel F Gradowski, Elaine S Jaffe, Roger A Warnke, et al.
Blood|March 10, 2011
Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphomaStefan D Dojcinov, Girish Venkataraman, Stefania Pittaluga, et al.
Blood|March 25, 2014
Ibrutinib inhibits BCR and NF-κB signaling and reduces tumor proliferation in tissue-resident cells of patients with CLLSarah E M Herman, Rashida Z Mustafa, Jennifer A Gyamfi, et al.
Blood|April 29, 2006
Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphomaMartina Rudelius, Stefania Pittaluga, Satoshi Nishizuka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 2015
A patient with Fever and rashMackenzie K Morgan, Timothy J Whitman, Jeffrey I Cohen, et al.
Cell Cycle (Georgetown, Tex.)|August 23, 2013
Loss of the proteins Bak and Bax prevents apoptosis mediated by histone deacetylase inhibitorsCaterina Ierano, Arup R Chakraborty, Alina Nicolae, et al.
Pediatrics|October 20, 2010
Highly variable clinical phenotypes of hypomorphic RAG1 mutationsElizabeth Mannino Avila, Gulbu Uzel, Amy Hsu, et al.
The American Journal of Surgical Pathology|February 28, 2012
Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphomaFranziska C Eberle, Joo Y Song, Liqiang Xi, et al.
Pageof 36